Page last updated: 2024-10-26

e 4031 and Myocardial Infarction

e 4031 has been researched along with Myocardial Infarction in 7 studies

E 4031: class III anti-arrhythmia agent; structure given in UD

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research Excerpts

ExcerptRelevanceReference
"Inducibility of ventricular arrhythmias was examined by programmed stimulation."1.31Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction. ( Kanki, H; Mitamura, H; Ogawa, S; Sueyoshi, K; Takatsuki, S, 2000)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogawa, S4
Mitamura, H3
Katoh, H2
Pinto, JM1
Boyden, PA1
Takatsuki, S2
Sueyoshi, K2
Kanki, H2
Furuno, I2
Holahan, MA1
Stranieri, MT1
Stabilito, II1
Lynch, JJ2
Heaney, LA1
Wallace, AA1
Gehret, JR1
Selnick, HG1
Stein, RB1
Sato, Y1
Yoh, S1
Saeki, K1
Nakamura, Y1

Other Studies

7 other studies available for e 4031 and Myocardial Infarction

ArticleYear
Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
    Cardiovascular drugs and therapy, 1993, Volume: 7 Suppl 3

    Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disease Models, Animal; Disopyrami

1993
Reduced inward rectifying and increased E-4031-sensitive K+ current density in arrhythmogenic subendocardial purkinje myocytes from the infarcted heart.
    Journal of cardiovascular electrophysiology, 1998, Volume: 9, Issue:3

    Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Ce

1998
Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction.
    Japanese heart journal, 1998, Volume: 39, Issue:5

    Topics: Animals; Anti-Arrhythmia Agents; Dogs; Electrophysiology; Female; Heart Conduction System; Humans; M

1998
Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models,

2000
Effect of E-4031, a class III antiarrhythmic agent, on experimental infarct size in a canine model of myocardial ischemia-reperfusion injury.
    Journal of cardiovascular pharmacology, 1992, Volume: 19, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Coronary Circulation; Dogs; Female; Hemodynamics; Male; Myocardial

1992
Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
    Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:5

    Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Blood Pressure; Chloralose; Dogs; Electric Stimulation;

1990
Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Dogs; Electric Stimulation; Electrodes; Electrophysiology; Heart Co

1990